“FibroScan led to a change in management in many of our patients confirming its value as a noninvasive adjunct for assessing hepatic fibrosis,” said Dr. Narang. He and his associates noted that the imaging technique was “guiding practice” and confirmed the “relative insensitivity of current methotrexate liver monitoring.”
Dr. Humphreys, Dr. Narang, and their associates had no relevant financial disclosures.